Bladder cancer and its declining awareness

Written By : Isra Zaman

Medically Reviewed By : Dr. Kamal Kant Kohli

Published On 2022-09-27 04:15 GMT | Update On 2022-09-27 04:15 GMT

Cancers are on a rise in India and bladder cancer is the 9th most common and leading cause of cancer in the country.However in few countries like Europe it is the fifth most common cancer in affecting over 200,000 people in every year.

It is caused by changes to the cells of the bladder and is often linked with exposure to certain chemicals. Smoking, for example, has been identified as the single biggest risk factor for bladder cancer. Common symptoms are usually related to urine and include blood in urine, changes in the colour of urine, pain when urinating, frequent urination and more.

A change in colour of urine or blood in urine is usually the first sign of bladder cancer and should prompt an immediate visit to a doctor or healthcare professional. However, over half (55%) of those surveyed did not know that a change in the colour of their urine could be an early indication of bladder cancer.

An early diagnosis of bladder cancer can significantly improve the treatment outcomes. One of the most common first indications of bladder cancer is the presence of blood in urine. According to the survey 75% of adults are not always checking their urine for a change in colour, with 22% rarely or never checking their urine.

The new survey has also shown that adults are unwilling to seek medical advice, even if they did notice symptoms. 20% of participants said that they would wait one week or longer before speaking to a doctor or healthcare professional if they noticed a change in the colour of their urine from yellow to orange, pink or red. The most common reason for not seeking medical advice was that people expected it to improve by itself.

Reference :

EUROPEAN ASSOCIATION OF UROLOGY

Full View

Article Source : EUROPEAN ASSOCIATION OF UROLOGY

Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.

NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.

Isra Zaman

Isra Zaman is a Life Science graduate from Daulat Ram College, Delhi University, and a postgraduate in Biotechnology from Amity University. She has a flair for writing, and her roles at Medicaldialogues include that of a Sr. content writer and a medical correspondent. Her news pieces cover recent discoveries and updates from the health and medicine sector. She can be reached at editorial@medicaldialogues.in.

Comments Policy

Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .

Bladder cancer and its declining awareness

Similar News

How Smoking Fuels Pancreatic Cancer Growth and Worsens Outcomes: Study Finds Out

New Urine Test May Detect Prostate Cancer with 91 Percent Accuracy: Study

India Sees Higher Cancer Incidence in Women but Greater Mortality in Men: ICMR Study

This Diet May Cut Risk of Cancer and Heart Disease Multimorbidity: Study Suggests

Real-World Case: Managing Chemotherapy-Induced Anemia in Metastatic Breast Cancer - Dr Akhil Kapoor

One Workout May Trigger Tumor-Suppressing Proteins in Cancer Survivors: Study Shows

New Web-Based Tool Aims to Cut Lung Cancer Deaths with Tailored Strategies, Reveals Research

Real-World Case study: Darbepoetin Alfa for Chemotherapy-Induced Anemia in Metastatic Rectal Cancer - Dr. Poulami Basu